In a Sept. 22 press convention, the Trump Administration launched what it says is an “thrilling therapy” for autism: leucovorin, a decades-old medication that treats poisonous results of chemotherapy. Early analysis suggests it may be useful for a sure group of individuals with a neurological situation associated to autism, although some medical consultants say it isn’t fairly prepared for use as extensively because the administration plans.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.